Advisor Net Financial, Inc Cytosorbents Corp Transaction History

Advisor Net Financial, Inc

  • $1.66 Billion
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 07, 2022
SELL
$1.76 - $3.22 $176 - $322
-100 Closed
0 $0
Q4 2021

Jan 19, 2022
SELL
$4.05 - $8.11 $4,050 - $8,109
-1,000 Reduced 90.91%
100 $0
Q1 2020

May 14, 2020
BUY
$3.77 - $7.73 $3,770 - $7,730
1,000 Added 1000.0%
1,100 $9,000
Q3 2018

Nov 14, 2018
BUY
$10.95 - $14.8 $1,095 - $1,480
100 New
100 $1,000

Others Institutions Holding CTSO

# of Institutions
51
Shares Held
16.7M
Call Options Held
28.9K
Put Options Held
0
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $34.9M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email